World Ovarian Cancer Day: 70% of Cases Diagnosed at Late Stage — Beware the Silent ‘King of Gynecological Cancers’

On World Ovarian Cancer Day, observed annually on May 8, health authorities and medical experts are drawing urgent attention to a disease often called the “silent killer” of women. According to a recent report featured on CCTV2’s First Time program, approximately 70% of ovarian cancer cases in China are diagnosed only when the disease has already reached an advanced stage. This stark statistic underscores the critical need for greater awareness of early symptoms and regular health screenings.

The Silent Threat of Ovarian Cancer

Ovarian cancer is frequently referred to as the “king of gynecological cancers” due to its high mortality rate and insidious onset. Unlike breast or cervical cancers, which have more established screening protocols and noticeable early warning signs, ovarian cancer often develops without clear symptoms. When symptoms do appear—such as abdominal bloating, pelvic pain, frequent urination, or feeling full quickly while eating—they are easily mistaken for common digestive or menstrual issues. This diagnostic delay is the primary reason why the majority of patients are already facing late-stage disease at the time of confirmation.

The challenges in early detection are compounded by the lack of a reliable, routine screening test for the general population. While transvaginal ultrasound and the CA-125 blood test are used, they are not recommended as universal screening tools for women without symptoms or high-risk factors. This makes education about risk factors and persistent symptoms all the more vital.

Understanding the Risk Factors

Medical experts highlighted in the broadcast that certain factors can increase a woman’s risk of developing ovarian cancer. These include advancing age, a family history of ovarian or breast cancer, inherited gene mutations such as BRCA1 and BRCA2, and a personal history of endometriosis. Women with these risk profiles are often advised to consult with a gynecologic oncologist about personalized surveillance strategies or preventive measures.

Conversely, factors such as long-term oral contraceptive use, multiple pregnancies, and breastfeeding have been associated with a reduced risk. However, these are not absolute protective measures, and vigilance remains essential for all women.

Advancing Treatment and the Importance of Specialized Care

While the statistics are sobering, the broadcast also noted that treatment for ovarian cancer has advanced significantly in recent years. Standard care typically involves a combination of cytoreductive surgery and platinum-based chemotherapy. More recently, the introduction of PARP inhibitors as maintenance therapy has improved progression-free survival for many patients, particularly those with BRCA mutations. The program emphasized that receiving care from a multidisciplinary team at a specialized cancer center can dramatically influence outcomes.

For patients navigating this diagnosis, seeking a second opinion or traveling to a high-volume medical center may provide access to clinical trials and the latest therapeutic protocols. This is an important consideration for patients both within China and those looking abroad for care.

Raising Awareness on World Ovarian Cancer Day

World Ovarian Cancer Day serves as a global platform to amplify the voices of survivors, honor those lost, and push for better research funding. The CCTV2 segment encouraged women to listen to their bodies and not dismiss persistent, vague symptoms. “If something feels off for more than two weeks, see a doctor,” one expert advised. “It’s probably not cancer, but if it is, early action can save your life.”

This expansion of public health messaging reflects the continued investment in gynecologic oncology care in China — relevant for patients exploring treatment options abroad. International patients considering China for medical care can find comprehensive cancer centers equipped with advanced diagnostic tools and experienced surgical teams, particularly in major cities like Shanghai, Beijing, and Guangzhou.

Reviewed by ToChinaMed. Published: 2026-05-08. This article is based on publicly available medical news and is not a substitute for professional medical advice.

ToChinaMed helps international patients find reliable medical treatment in China.

Source: CCTV.com / 复旦大学附属肿瘤医院